# A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma

> **NCT00082082** · PHASE2 · COMPLETED · sponsor: **SciClone Pharmaceuticals**

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** Thymalfasin (thymosin alpha-1)
- **PROCEDURE:** Trans arterial chemoembolization (TACE)

## Key facts

- **NCT ID:** NCT00082082
- **Lead sponsor:** SciClone Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082082, "A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00082082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*